# Syncom Formulations India Ltd-$ (SYNCOMF)
> Exchange: NSE | Sector: Pharma | ISIN: INE312C01025

## About
Syncom Formulations India Ltd-$ is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 69.88%

## Profitability
ROE: 20.1%

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-10-21T08:31:24.000Z
Price History Updated: 2026-10-26T16:56:34.131Z
Latest Price History Date: 2026-10-21
Technicals Updated: 2026-10-26T16:56:34.131Z
Quant Updated: 2026-10-26T16:56:34.131Z
Sentiment Updated: 2026-10-26T16:56:34.131Z
Financials Status: current
Financials Updated: 2026-09-23T06:35:25.112Z
Financials Last Attempt: 2026-10-25T11:35:30.379Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹498 Cr
Operating Profit: ₹88 Cr (OPM 18%)
Net Profit: ₹86 Cr
Tax: ₹27 Cr

## Annual P&L History
TTM: Rev ₹498Cr | PAT ₹86Cr | OPM 18%
FY26: Rev ₹488Cr | PAT ₹76Cr | OPM 16%
FY25: Rev ₹463Cr | PAT ₹49Cr | OPM 12%

## Balance Sheet (FY26)
Total Assets: ₹534 Cr
Total Liabilities: ₹534 Cr
Borrowings: ₹1 Cr
Cash: —

## Shareholding
Promoters: 50.57%
FIIs: 0.35%
Public: 49.07%

---
Source: rupiya.io/stocks/syncomf
Disclaimer: For research and education only. Not investment advice.